AU6012696A - Prognostic and therapeutic system for cancer - Google Patents

Prognostic and therapeutic system for cancer

Info

Publication number
AU6012696A
AU6012696A AU60126/96A AU6012696A AU6012696A AU 6012696 A AU6012696 A AU 6012696A AU 60126/96 A AU60126/96 A AU 60126/96A AU 6012696 A AU6012696 A AU 6012696A AU 6012696 A AU6012696 A AU 6012696A
Authority
AU
Australia
Prior art keywords
prognostic
cancer
therapeutic system
therapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60126/96A
Inventor
Margaret Ellen Duncan
John Edward Fothergill
William Thomas Melvin
Graeme Ian Murray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9512085.3A external-priority patent/GB9512085D0/en
Priority claimed from GBGB9602982.2A external-priority patent/GB9602982D0/en
Application filed by University of Aberdeen filed Critical University of Aberdeen
Publication of AU6012696A publication Critical patent/AU6012696A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AU60126/96A 1995-06-14 1996-06-13 Prognostic and therapeutic system for cancer Abandoned AU6012696A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9512085.3A GB9512085D0 (en) 1995-06-14 1995-06-14 Diagnostic antibody system
GB9512085 1995-06-14
GB9602982 1996-02-14
GBGB9602982.2A GB9602982D0 (en) 1996-02-14 1996-02-14 Diagnostic antibody system
PCT/GB1996/001423 WO1997000449A1 (en) 1995-06-14 1996-06-13 Prognostic and therapeutic system for cancer

Publications (1)

Publication Number Publication Date
AU6012696A true AU6012696A (en) 1997-01-15

Family

ID=26307212

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60126/96A Abandoned AU6012696A (en) 1995-06-14 1996-06-13 Prognostic and therapeutic system for cancer

Country Status (2)

Country Link
AU (1) AU6012696A (en)
WO (1) WO1997000449A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002526772A (en) * 1998-10-08 2002-08-20 カルバイオケム ノババイオケム コーポレイション Diagnostic assays for matrix metalloproteinase 9 and uses thereof
US7101975B1 (en) * 1999-07-13 2006-09-05 University Of Southern California Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins
DK2185175T3 (en) 2007-08-15 2013-05-13 Yeda Res & Dev MMP-9 controllers and their applications
CN101738478A (en) * 2008-11-27 2010-06-16 浙江大学 Application of MMP9 (matrix metalloproteinase 9) as diagnosis marker of ovarian cancer
JP2013532482A (en) 2010-07-27 2013-08-19 ジェノミック ヘルス， インコーポレイテッド Methods for quantifying prostate cancer prognosis using gene expression
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
PT3388075T (en) 2015-03-27 2023-08-18 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003)
CN114252609A (en) * 2021-12-23 2022-03-29 武汉生之源生物科技股份有限公司 Detection kit and detection method for matrix metalloproteinase-9

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer

Also Published As

Publication number Publication date
WO1997000449A1 (en) 1997-01-03

Similar Documents

Publication Publication Date Title
AU7310696A (en) Dsplay system
EP1376882A3 (en) Vehicle computer system
AU7163796A (en) Security system
AUPN564395A0 (en) Multivenue jackpot system
AUPN733395A0 (en) Location and tracking system
AU5268696A (en) Novel compounds and methods for therapy
AU6624696A (en) Data processing system
AU5586398A (en) Submersive therapy apparatus
AU4917596A (en) Perfusion system
AU6656796A (en) Transcorneal drug-release system
AU4957197A (en) Transaction system
PL323534A1 (en) Radiotelephony data stransmission system
AU1349697A (en) Total body cooling system
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU6980696A (en) Multivenue jackpot system
AU7166896A (en) Cancer treatment
GB9509572D0 (en) Cancer therapy
AU6012696A (en) Prognostic and therapeutic system for cancer
AU6657396A (en) Transdermal system
AU5483896A (en) Gel casting system
AU1322497A (en) Computing system
AU5404996A (en) Construction system
AU7526896A (en) Dosage modeling system
AU5597696A (en) Treatment system
AU4726796A (en) Massage system